槐耳颗粒对乳腺癌术后化疗患者免疫功能及生活质量的影响-东南大学学报医学版

槐耳颗粒对乳腺癌术后化疗患者免疫功能及生活质量的影响

作者：鲁明骞¹ 冯雪松¹ 孔庆志² 夏忠军³ 许新华¹ 李薇¹ 刘洋¹ 徐冰清¹

单位：1. 三峡大学第一临床医学院肿瘤防治中心/宜昌市中心人民医院肿瘤科, 湖北宜昌 443000;
2. 武汉市中心医院/武汉市肿瘤研究所, 湖北武汉 430061;
3. 中山大学肿瘤防治中心, 广东广州 510060

分类号：R285.6;R737.9

出版年·卷·期（页码）：2017·36·第四期（567-571）

摘要：

目的：探讨槐耳颗粒对乳腺癌术后化疗患者外周血细胞免疫功能及生活质量的影响。方法：将90例乳腺癌术后患者随机分为治疗组和对照组。治疗组行"FEC"（环磷酰胺0.6 g·m^-2，d1；表柔比星100 mg·m^-2，d1；氟尿嘧啶0.6 g·m^-2，d1）方案化疗，同时给予槐耳颗粒口服，20 g·次^-1，3次·d^-1，连续服用2个月；对照组单纯行"FEC"方案化疗。2周期后对患者生活质量、临床症状及免疫功能进行评价。结果：两组患者治疗前外周血NK细胞、CD3⁺、CD4⁺、CD4⁺/CD8⁺值差异无统计学意义；2周期后治疗组各项免疫指标明显优于对照组，差异具有统计学意义（P<0.05）。在改善中医症候群和提高生活质量评分中，治疗组明显高于对照组，差异具有统计学意义（P<0.05）。结论：槐耳颗粒能提高乳腺癌术后化疗患者的免疫功能，改善临床症状，提高生活质量，值得临床进一步研究。

Objective:To study the effect of Huaier Granule on immune function and quality of life in patients with breast cancer after operation and chemotherapy. Methods:A total of 90 patients were confirmed by pathology examination after operation for breast cancer, and were randomly divided into two groups:treatment group receiving chemotherapy of FEC scheme (0.6 g·m^-2 cyclophosphamide, intravenous injection, d1; 100 mg·m^-2 epirubicin, intravenous drip, d1; 0.6 g·m^-2 5-fluorouracil, intravenous drip, dl), and oral Huaier Granule (20 g each time, 3 times·d^-1, 21 days for a cycle), control group was only given chemotherapy of FEC scheme. Peripheral NK cells, CD3⁺, CD4⁺, and CD4⁺/CD8⁺ ratio were determined before and after the chemotherapy. The quality of life, clinical efficacy and immune function were compared between the two groups after 2 cycles. Results:There were no statistically significant differences (P>0.05) between the treatment group and the control group in peripheral NK cells, CD3⁺,CD4⁺,and CD4⁺/CD8⁺ ratio. After the treatment for 2 weeks, NK cells, CD3⁺, CD4⁺ and CD4⁺/CD8⁺ ratio of the patients were higher in the treatment group than those of the control group (P<0.05). In terms of improving TCM symptom and the quality of life scores, the treatment group was significantly better than the control group, with a significant difference (P<0.05). Conclusion:Huaier Granule can enhance the immunity, improve the clinical efficacy and quality of life of the breast cancer patients with postoperative chemotherapy. Therefore, it is worthy of further clinical research.

参考文献：

[1] JEMAL A,BRAY F,CENTER M M,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(11):69-90.
[2] 毛思颖,曹海明,陈前军.槐耳颗粒治疗乳腺癌的研究进展[J].中成药,2016,38(6):1363-1367.
[3] 郑筱萸.中国新药临床研究指导原则[M].北京:中国医药科技出版社,2002:250-383.
[4] SCHREIBER R D,OLD L J,SMYTH M J.Cancer immunoediting:integrating immunity's roles in cancer suppression and promotion[J].Science,2011,331(6024):1565-1570.
[5] 刘敏,王明武.解毒破淤法抑制三阴性乳腺癌复发与转移的临床研究[J].南京中医药大学学报,2016,32(2):111-113.
[6] DeSANTIS C,SIEGEL R,BANDI P,et al.Breast cancer statistics,2011[J].CA Cancer J Clin,2011,61(6):409-418.
[7] SIEGEL R L,MILLER K D,JEMAL A.Cancer Statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
[8] 代佑果,寸英丽.槐耳颗粒联合化疗对乳腺癌患者细胞免疫功能的影响[J].现代肿瘤医学,2007,15(10):1438-1439.
[9] 刘聪,孙秀华.槐耳颗粒对30例晚期胃癌患者T细胞亚群的影响[J].医学综述,2013,19(7):1292-1293.
[10] 冯海华,尤振宇,刘宝红.槐耳颗粒辅助腹腔热灌注化疗联合高频热疗对胃肠肿瘤术后患者免疫功能与生存的影响[J].肿瘤药学,2013,3(1):51-55,80.
[11] 张超,冯秀芳,王秀云,等.小金丸联合多西他赛、表柔比星、环磷酰胺治疗Ⅲ期乳腺癌的疗效及对患者免疫功能的影响[J].中国药房,2016,27(15):2059-2061.
[12] O'SHAUGHNESSY J A,WITTES R E,BURKE G,et al.Commentary concening demonstration of safety and efficacy of investigational anticancer agents in clinical trials[J].J Clin Oncol,1991,9(12):2225-2232.
[13] 莫斌,杨家印,严律南,等.槐耳颗粒用于肝癌移植术后的临床观察[J].四川大学学报:医学版,2011,42(5):739-741.
[14] 王红梅,刘士欣,廖国清,等.槐耳颗粒联合多西他赛治疗老年肺小细胞肺癌的临床研究[J].中国医院医药评价与分析,2011,11(4):356-358.
[15] 鲁明骞,孔庆志.槐耳制剂治疗乳腺癌的作用及机理研究[J].湖北中医药大学学报,2015,17(5):101-103.
[16] 殷星,候永超,王梅云,等.观察槐耳颗粒治疗老年乳腺癌的临床疗效[J].中医中药,2013,11(20):280-281.
[17] 钟少文,江慧玲,刘鑫,等.金克槐耳颗粒治疗Ⅳ期乳腺癌[J].中国肿瘤,2003,12(12):754-755.
[18] 鲁明骞,卢宏达,孔庆志.槐耳治疗恶性肿瘤的研究进展[J].中国中医基础医学杂志,2015,21(12):1607-1609.
[19] 木妮热·木沙江,陈惠,司马义力·买买提尼牙孜,等.槐耳颗粒在乳腺癌放疗中的应用[J].肿瘤学杂志,2005,11(6):461-462.
[20] 付美兰,郭丽英,玛伊努尔,等.槐耳颗粒对43例晚期乳腺癌化疗患者造血及免疫功能影响[J].肿瘤学杂志,2005,11(4):318-318.
[21] 吴飞雪,宇明慧,许晓洲.槐耳颗粒联合化疗治疗复发晚期非小细胞肺癌的临床观察[J].中国中医药现代远程教育,2013,10(6):17-19.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录